PharmaTher Holdings Ltd has announced that it is on track to submit responses to the FDA regarding its ketamine drug, with an expected approval date in Q2-2025. The company plans to focus on ...
Recreational ketamine use has increased in the United States in recent years, outpacing its rise as a treatment for depression, a new analysis suggests. The hallucinogenic drug — a controlled ...